US · Healthcare · Medical Care Facilities
EPS came in at 0.44 against a street estimate of 0.38 — a beat of 15.8%.
Analysts rate Mednax Inc a buy (3 buy, 5 hold, 0 sell out of 8) with an average price target of $24.50.
| Fund | Stake |
|---|---|
| BlackRock Inc | 16.53% |
| Vanguard Portfolio Management, LLC | 7.49% |
| American Century Companies Inc | 4.78% |
| Dimensional Fund Advisors, Inc. | 4.70% |
| Victory Capital Management Inc. | 4.68% |
| Vanguard Capital Management, LLC | 4.45% |
| State Street Corp | 4.11% |
| Wasatch Advisors LP | 3.04% |
| Document | Date |
|---|---|
| Board / officer change · Q3 2026 | 2026-07-24 |
| Results announced · Q3 2026 | 2026-07-15 |
| Board / officer change · Q2 2026 | 2026-05-07 |
| Quarterly report · Q1 2026 | 2026-05-05 |
| Results announced · Q2 2026 | 2026-05-05 |
| Proxy statement · Q1 2026 | 2026-03-27 |
| Annual report FY2025 | 2026-02-19 |
| Quarterly report · Q3 2025 | 2025-11-03 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Mednax Inc — free to start.
Google PlayApp StoreData updated 2026-08-05.